January 31, 2018

Senators Shaheen, Hassan Request GAO Review of Trump Administration’s Failure to Meaningfully Address Opioid Epidemic

The Administration Has Done Little to Nothing Since Declaring the Crisis a Public Health Emergency


Washington, DC – Senators Jeanne Shaheen (D-NH) and Maggie Hassan (D-NH) joined colleagues in requesting that the Government Accountability Office (GAO) review actions taken by President Trump’s Administration to address the opioid epidemic since he declared it a public health emergency.


On October 26, 2017, when President Trump directed the Department of Health and Human Services (HHS) to declare the opioid crisis a public health emergency, he stated that the emergency declaration would “allow for expanded access to telemedicine services” for addiction treatment; permit the Department of Health and Human Services to hire temporary “specialists with the tools and talent needed to respond effectively” to the opioid crisis; allow “the Department of Labor to issue dislocated worker grants to help workers…displaced from the workforce because of the opioid crisis;” and potentially enable the “shifting of resources within HIV/AIDS programs to help people eligible…receive substance abuse treatment.”


“Given the severity of the crisis, we have grown increasingly concerned by reports that the President has done little to make use of his public health emergency declaration, leaving state and local communities without the resources they need to fight the opioid epidemic,” the senators wrote in a letter. “Despite saying it would work with Congress, the White House has put forward no proposals for authorizing new funding.”


Despite calls from Senators Shaheen and Hassan, as well as bipartisan calls from governors and legislators to do so, the Trump Administration has yet to officially allocate new funds to address the opioid crisis. His new Secretary of Health and Human Services, Alex Azar, has also refused to commit to supporting new funding to address the crisis. Instead, the President again plans to cut funding for the White House Office of National Drug Policy (ONDCP) and has failed to fill key leadership positions that require a deep understanding of this public health crisis – including the Drug Enforcement Administration (DEA) administrator and the Director of the ONDCP. Telemedicine initiatives the President discussed have not been implemented, and the Department of Labor has yet to issue grants for dislocated workers.


The President’s initial emergency declaration expired on January 23, 2018. On January 24th, Acting HHS Secretary Eric Hargan extended the emergency for another 90 days. To ensure the federal government utilizes all available resources to prevent and treat opioid addiction, as well as utilize available resources efficiently and effectively, the senators requested a GAO review of the resources available to the executive branch to combat the opioid epidemic and the steps the Trump Administration has taken since declaring the crisis a public health emergency.


Senators Shaheen and Hassan have been pushing for $25 billion in additional funding to combat the opioid crisis to be included in the long-term funding bill that’s currently being negotiated. The Senators also called on the President to nominate strong, experienced leadership to key drug policy positions.


They joined Senators Elizabeth Warren (D-Mass.), Patty Murray (D-W.A.), Edward Markey (D-Mass.), Bob Casey (D-Pa.), Bill Nelson (D-Fla.), Joe Donnelly (D-Ind.), Brian Schatz (D-Hawaii), Debbie Stabenow (D-Mich.), Sherrod Brown (D-Ohio), Tammy Baldwin (D-Wis.), Dianne Feinstein (D-Calif.), Kirsten Gillibrand (D-N.Y.), Sheldon Whitehouse (D-R.I.), Tim Kaine (D-Va.), and Tammy Duckworth (D-Ill.) in sending the letter.


Click HERE for full text of the letter